References
- Martin D S, Fugmann R A, Hayworth P. Surgery. cancer chemotherapy, host defences aid tumor size. J Natl Cancer Inst 1962; 29: 817
- Mihich E. Combined effects of chemotherapy and immunity against leukemia L1210 in DBA/2 mice. Cancer Res 1969; 29: 848
- Bonmassar E, Cudkowicz G, Vadlamudi S, Goldin A. Influence of tumor-host differences at a single histocompatibility locus (h-1) on the antileukemic effect of 1, 3-bis (2-chloroethyl)-1-nitrosourea (NSC-409962). Cancer Res 1970; 30: 2538
- Pearson J W, Pearson G R, Gibson W T, Cherman J C, Chirigos M A. Combined chemo-immunostimulation therapy against murine leukemia. Cancer Res 1972; 32: 904
- Riccardi C, Bartocci A, Puccetti P, Spreafico F, Bonmassar E, Goldin A. Combined effects of antineoplastic agents and anti-lymphoma allograft reactions. Eur J Cancer 1980; 16: 23
- Calabresi P, Parks R E, Jr. The pharmacological basis of therapeutics, 7th ed., A Goodman Gilman, L S Goodman, T W Rall, F Murad. Macmillan, New York 1985; 1277
- Giampietri A, Bonmassar E, Goldin A. Drug-induced modulation of immune responses in mice: effects of 5—(3, 3′-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) and cyclophosphamide (CY). J Immunopharm 1978; 1: 61
- Glynn J P, Bianco A R, Goldin A. Studies on induced resistance against iso-transplants of virus-induced leukemia. Cancer Res 1964; 24: 502
- Lozzio B, Lozzio C B, Bamberger E G, Feliu A S. Multipotential leukemia cell line (K562) of human origin. Proc Soc Exp Biol Med 1981; 166: 546
- Miyoshi I, Kubonishi I, Yoshimoto S, Akagi T, Outsuki Y, Shimaishi Y, Nagata K, Hinuma Y. Type C virus particles in a cord blood line derived by co-cultivating normal human cord lymphocytes and human leukemic T cells. Nature 1981; 294: 770
- Van de Griend R J, Van Krimpen B A, Bol S JL, Thompson A, Bolhuis R LH. Rapid expansion of human cytotoxic T cell clones: growth promotion by a heat-labile serum component and by various types of feeder cells. J Immunol Methods 1984; 66: 285
- Boyum A. Isolation of lymphocytes from human blood. Further observation. Scand J Clin Lab Invest 1968; 21: 31
- Thorn R M, Henney C S, Kinleti C. Analysis of target cell destruction of effector T cells: I. Deliniation of parameters related to the frequency of killer cells. J Immunol 1976; 117: 2213
- Robert-Guroff M, Ruscetti F W, Posner L E, Poiesz B J, Gallo R C. Detection of the human T-cell lymphoma virus p19 in cells of some patients with cutaneous T-cell lymphoma and leukemia using a monoclonal antibody. J Exp Med 1981; 154: 1957
- Bier H. Animal experiments on the role of T lymphocytes in the course of antineoplastic chemotherapy. II. Chemotherapy and T lymphocyte depression. J Otorhinolaryngol Relat Spec 1987; 49: 57
- Watanabe N, Niitsu Y, Yamauchi N, Ohtsuka Y, Sone H, Neda H, Maeda M, Urushizaki I. Synergistic cytotoxicity of recombinant human TNF and various anti-cancer drugs. Immunopharmacol Immunotoxicol 1988; 10: 117
- Sieber S M, Mead J AR, Adamson R H. Pharmacology of antitumor agents from higher plants. Cancer Treat Rep 1976; 60: 1127
- Neubauer A, Sauer H, Valet G. Cytostatic drug testing in human leukemias by means of multiparametric flow cytometry. Blut 1987; 55: 433
- Berke G. Cytotoxic T-lymphocytes: how do they function. Immunol Rev 1983; 72: 5
- De Vecchis L, Graziani G, Macchi B, Grandori C, Pastore S, Popovic M, Gallo R C, Bonmassar E. Decline of natural cytotoxicity of human lymphocytes following infection with human T-cell leukemia/lymphoma virus (HTLV). Leukemia Res 1985; 9: 349
- Yarchoan R, Guo H G, Reitz M, Maluish A, Mitsuya H, Broder S. Alterations in cytotoxic and helper T cell function after infection of T cell clones with human T cell leukemia virus, type I. J Clin Invest 1986; 77: 1466
- Faller D V, Crimmins M AV, Mentzer S J. Human T-cell leukemia virus type I infection of CD4+ or CD8+ cytotoxic T-cell clones results in immortalization with retention of antigen specificity. J Virol 1988; 62: 2942
- Ahmed K, Abdul Hamied T A, Turk J L. Inhibition of release of interleukine-2 by vincristine and vinblastine. Immunopharmacol Immunotoxicol 1987; 9: 391
- Bartocci A, Riccardi C, Bonmassar E. In vivo or in vitro modulating effects of vincristine on the generation of allogeneic cytotoxic lymphocytes in vitro. J Immunopharmacol 1980; 2: 61
- Katz P, Zaytoun A M, Lee J H, Jr. Mechanisms of human cell-mediated cytotoxicity. III. Dependence of natural killing on microtubule and microfilament integrity. J Immunol 1982; 129: 2816